Walleye Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,943,046
| Closed | -$3.56M | – | 2234 |
|
|
2024
Q4 | $3.56M | Buy |
1,943,046
+1,698,931
| +696% | +$3.11M | 0.01% | 528 |
|
|
2024
Q3 | $415K | Buy |
244,115
+89,484
| +58% | +$152K | ﹤0.01% | 1425 |
|
|
2024
Q2 | $212K | Buy |
154,631
+148,209
| +2,308% | +$203K | ﹤0.01% | 1842 |
|
|
2024
Q1 | $24.1K | Sell |
6,422
-31,323
| -83% | -$117K | ﹤0.01% | 2229 |
|
|
2023
Q4 | $370K | Buy |
+37,745
| New | +$370K | ﹤0.01% | 1272 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2779 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2649 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2555 |
|
|
2022
Q2 | – | Sell |
-51,225
| Closed | -$466K | – | 2572 |
|
|
2022
Q1 | $466K | Buy |
51,225
+41,272
| +415% | +$375K | 0.01% | 1010 |
|
|
2021
Q4 | $204K | Buy |
+9,953
| New | +$204K | 0.01% | 1425 |
|
|
2021
Q3 | – | Sell |
-6,100
| Closed | -$213 | – | 1723 |
|
|
2021
Q2 | $213 | Buy |
+6,100
| New | +$213 | 0.01% | 1026 |
|
|
2020
Q4 | – | Sell |
-19,720
| Closed | -$195K | – | 1060 |
|
|
2020
Q3 | $195K | Buy |
19,720
+9,720
| +97% | +$96.1K | 0.02% | 607 |
|
|
2020
Q2 | $35K | Buy |
+10,000
| New | +$35K | 0.01% | 560 |
|